Our research supports that stroma-secreted ASPN binds to HER3 on adjacent prostate cancer cells and induces phosphorylation of its preferential dimerization partner, HER2, thereby activating multiple ErbB-associated downstream signaling pathways and increasing cellular migration. The gene discussed is ERBB2; the disease is prostate carcinoma.